BIO FY 2013 Earnings Report — Bio-Rad Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

Bio-Rad Laboratories, Inc.BIO

FY 2013 Earnings

Reported March 17, 2014

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2013	Prior Q	FY 2012	QoQ Change	YoY Change
Revenue	$2.1B	—	—	—	—
Op. Income	$169M	—	—	—	—
Gross Margin	55.3%	—	—	—	—
Net Margin	3.6%	—	—	—	—
EPS (Diluted)	$2.69	—	—	—	—
Free Cash Flow	$62M	—	—	—	—

Revenue Flow

Item	Amount
REVENUE	$2.1B
Cost of Revenue	$954M
GROSS PROFIT	$1.2B
R&D Expenses	$211M
Selling & Marketing	$0
General & Administrative	$798M
SG&A Expenses	$798M
Other Expenses	$0
Operating Expenses	$1.0B
Cost & Expenses	$2.0B
OPERATING INCOME	$169M
Interest Income	$13M
Interest Expense	$61M
Other Income/Expenses	-$57M
INCOME BEFORE TAX	$112M
Income Tax Expense	$35M
Net Income from Continuing Ops	$78M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$78M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$78M
D&A	$147M
EBIT	$174M
EBITDA	$305M
EPS	$3
EPS Diluted	$3

Income Statement

Item	Amount
REVENUE	$2.1B
Cost of Revenue	$954M
GROSS PROFIT	$1.2B
R&D Expenses	$211M
Selling & Marketing	$0
General & Administrative	$798M
SG&A Expenses	$798M
Other Expenses	$0
Operating Expenses	$1.0B
Cost & Expenses	$2.0B
OPERATING INCOME	$169M
Interest Income	$13M
Interest Expense	$61M
Other Income/Expenses	-$57M
INCOME BEFORE TAX	$112M
Income Tax Expense	$35M
Net Income from Continuing Ops	$78M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$78M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$78M
D&A	$147M
EBIT	$174M
EBITDA	$305M
EPS	$3
EPS Diluted	$3

Cash Flow Statement

Item	Amount
Net Income	$78M
Depreciation & Amortization	$147M
Stock-Based Compensation	$14M
Deferred Income Tax	$0
Other Non-Cash Items	-$7M
Change in Working Capital	-$62M
OPERATING CASH FLOW	$169M
Capital Expenditure	-$107M
Acquisitions (Net)	-$72M
Purchases of Investments	-$387M
Sales/Maturities of Investments	$566M
Other Investing Activities	$1M
NET CASH FROM INVESTING	$919.0K
Net Debt Issuance	-$300M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	-$23M
NET CASH FROM FINANCING	-$312M
FREE CASH FLOW	$62M
Net Change in Cash	-$132M

Balance Sheet

Item	Amount
Cash & Equivalents	$332M
Short-Term Investments	$277M
Net Receivables	$423M
Inventory	$516M
Other Current Assets	$79M
TOTAL CURRENT ASSETS	$1.8B
PP&E (Net)	$414M
Goodwill	$518M
Intangible Assets	$266M
Long-Term Investments	$378M
Tax Assets	$0
Other Non-Current Assets	$55M
TOTAL NON-CURRENT ASSETS	$1.6B
TOTAL ASSETS	$3.4B
Account Payables	$149M
Short-Term Debt	$2M
Deferred Revenue	$26M
Other Current Liabilities	$117M
TOTAL CURRENT LIABILITIES	$487M
Long-Term Debt	$436M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$162M
Other Non-Current Liabilities	$117M
TOTAL NON-CURRENT LIABILITIES	$715M
TOTAL LIABILITIES	$1.2B
Common Stock	$3.0K
Additional Paid-In Capital	$240M
Retained Earnings	$1.6B
Treasury Stock	-$101.0K
Accum. Other Comp. Income	$341M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$2.2B
Minority Interest	$0
TOTAL EQUITY	$2.2B
TOTAL LIABILITIES & EQUITY	$3.4B
Total Debt	$437M
Net Debt	$106M